发明名称 |
MATERIAL AND METHOD FOR TREATING INTERNAL CAVITIES |
摘要 |
A hydrophilic biocompatible sustained-release material is disclosed. The material comprises amounts of Pluronic F-127, PEG-400, HPMC and water, effective to produce a composition of sufficiently low viscosity at room temperature to be injectable into an internal body cavity via a tube inserted within a urinary catheter. At body temperature, the material exhibits a much higher viscosity and will stably adhere to the internal surface of a body cavity. As the material dissolves, a therapeutic agent incorporated therein is slowly released to the body cavity, while the material itself is excreted from the body. |
申请公布号 |
US2015366974(A1) |
申请公布日期 |
2015.12.24 |
申请号 |
US201514720676 |
申请日期 |
2015.05.22 |
申请人 |
Theracoat Ltd. |
发明人 |
Holzer Asher;Daniel Dorit;Mullerad Michael;De La Zerda Jaime;Shpolansky Uri;Malchi Nadav;Dollberg Yosh;Tal Dor;Yavin Yossi;Konorty Marina |
分类号 |
A61K47/34;A61K38/20;A61K38/48;A61K31/407;A61K31/704 |
主分类号 |
A61K47/34 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a urinary tract cancer comprising:
obtaining a pharmaceutical composition comprising an effective amount of a therapeutic agent and a thermoreversible hydrogel; wherein the thermoreversible hydrogel comprises: (i) 18% (w/w) to 40% (w/w) ethylene oxide/propylene oxide block copolymer, (ii) 0.05% (w/w) to 0.5% (w/w) HPMC, and (iii) water; and administering the pharmaceutical composition to a human in need thereof. |
地址 |
Raanana IL |